Legal Representation
Attorney
CHRISTOPHER D. CASAVALE
USPTO Deadlines
Application History
49 eventsDate | Code | Type | Description |
---|---|---|---|
Mar 24, 2025 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
Mar 24, 2025 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED |
Aug 6, 2024 | DPCC | D | DIVISIONAL PROCESSING COMPLETE |
Jul 19, 2024 | ERTD | I | TEAS REQUEST TO DIVIDE RECEIVED |
Jul 19, 2024 | DRRR | I | DIVISIONAL REQUEST RECEIVED |
Jun 22, 2024 | EX5G | S | SOU EXTENSION 5 GRANTED |
Jun 22, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Jun 18, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
Jun 18, 2024 | EXT5 | S | SOU EXTENSION 5 FILED |
Apr 25, 2024 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
Apr 25, 2024 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
Apr 25, 2024 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
Apr 25, 2024 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
Apr 25, 2024 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
Feb 22, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Feb 21, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
Feb 21, 2024 | EXT4 | S | SOU EXTENSION 4 FILED |
Feb 21, 2024 | EX4G | S | SOU EXTENSION 4 GRANTED |
Jan 10, 2024 | NOAC | E | CORRECTED NOA E-MAILED |
Jan 9, 2024 | DPCC | D | DIVISIONAL PROCESSING COMPLETE |
Jan 5, 2024 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
Oct 30, 2023 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
Oct 4, 2023 | ERTD | I | TEAS REQUEST TO DIVIDE RECEIVED |
Oct 4, 2023 | DRRR | I | DIVISIONAL REQUEST RECEIVED |
Aug 19, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Aug 18, 2023 | EX3G | S | SOU EXTENSION 3 GRANTED |
Aug 18, 2023 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
Aug 11, 2023 | EXT3 | S | SOU EXTENSION 3 FILED |
Aug 11, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
Feb 24, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Feb 22, 2023 | EXT2 | S | SOU EXTENSION 2 FILED |
Feb 22, 2023 | EX2G | S | SOU EXTENSION 2 GRANTED |
Feb 22, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
Aug 24, 2022 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Aug 22, 2022 | EX1G | S | SOU EXTENSION 1 GRANTED |
Aug 22, 2022 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
Aug 22, 2022 | EXT1 | S | SOU EXTENSION 1 FILED |
Feb 22, 2022 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
Dec 28, 2021 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Dec 28, 2021 | PUBO | A | PUBLISHED FOR OPPOSITION |
Dec 8, 2021 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Nov 19, 2021 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
Nov 19, 2021 | XAEC | I | EXAMINER'S AMENDMENT ENTERED |
Nov 19, 2021 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
Nov 19, 2021 | GNEA | F | EXAMINERS AMENDMENT E-MAILED |
Nov 19, 2021 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN |
Nov 12, 2021 | DOCK | D | ASSIGNED TO EXAMINER |
Jul 8, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Apr 3, 2021 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 005
Human cells for medical or clinical therapeutic purposes; cell growth media for growing specialized human cells for medical or clinical use; cell growth media for growing non-specialized human cells for medical or clinical use
Classification
International Classes
005